nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—CYP3A4—bone cancer	0.285	1	CbGaD
Carbamazepine—RALBP1—Doxorubicin—bone cancer	0.238	0.439	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—bone cancer	0.0895	0.165	CbGbCtD
Carbamazepine—ABCC2—Carboplatin—bone cancer	0.0437	0.0804	CbGbCtD
Carbamazepine—ABCC2—Cisplatin—bone cancer	0.0373	0.0687	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—bone cancer	0.025	0.046	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—bone cancer	0.0242	0.0446	CbGbCtD
Carbamazepine—CYP2B6—Cisplatin—bone cancer	0.0237	0.0437	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—bone cancer	0.0159	0.0293	CbGbCtD
Carbamazepine—CYP2C9—Cisplatin—bone cancer	0.0125	0.0231	CbGbCtD
Carbamazepine—ABCB1—Cisplatin—bone cancer	0.0122	0.0224	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—bone cancer	0.00815	0.015	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—bone cancer	0.0079	0.0145	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—bone cancer	0.00489	0.00899	CbGbCtD
Carbamazepine—Nepafenac—PTGS2—bone cancer	0.000433	0.123	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—bone cancer	0.000423	0.12	CrCbGaD
Carbamazepine—Salsalate—PTGS2—bone cancer	0.00036	0.102	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—bone cancer	0.00036	0.102	CrCbGaD
Carbamazepine—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.00031	0.00624	CbGpPWpGaD
Carbamazepine—Alimemazine—CYP3A4—bone cancer	0.000302	0.086	CrCbGaD
Carbamazepine—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000298	0.006	CbGpPWpGaD
Carbamazepine—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000289	0.00581	CbGpPWpGaD
Carbamazepine—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000283	0.00569	CbGpPWpGaD
Carbamazepine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000282	0.00567	CbGpPWpGaD
Carbamazepine—Cyclobenzaprine—CYP3A4—bone cancer	0.000278	0.0793	CrCbGaD
Carbamazepine—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000276	0.00557	CbGpPWpGaD
Carbamazepine—Epinastine—CYP3A4—bone cancer	0.000276	0.0787	CrCbGaD
Carbamazepine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000275	0.00554	CbGpPWpGaD
Carbamazepine—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000272	0.00547	CbGpPWpGaD
Carbamazepine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00027	0.00544	CbGpPWpGaD
Carbamazepine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000268	0.0054	CbGpPWpGaD
Carbamazepine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000263	0.00529	CbGpPWpGaD
Carbamazepine—Oxcarbazepine—CYP3A4—bone cancer	0.000255	0.0725	CrCbGaD
Carbamazepine—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000252	0.00508	CbGpPWpGaD
Carbamazepine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000252	0.00507	CbGpPWpGaD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—KIT—bone cancer	0.000245	0.00493	CbGpPWpGaD
Carbamazepine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000241	0.00486	CbGpPWpGaD
Carbamazepine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000232	0.00468	CbGpPWpGaD
Carbamazepine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00023	0.00464	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—BRAF—bone cancer	0.000229	0.00462	CbGpPWpGaD
Carbamazepine—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000227	0.00458	CbGpPWpGaD
Carbamazepine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000215	0.00434	CbGpPWpGaD
Carbamazepine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000213	0.00429	CbGpPWpGaD
Carbamazepine—UGT2B7—Phase II conjugation—GSTP1—bone cancer	0.000212	0.00427	CbGpPWpGaD
Carbamazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000209	0.0042	CbGpPWpGaD
Carbamazepine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000208	0.00418	CbGpPWpGaD
Carbamazepine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000198	0.00398	CbGpPWpGaD
Carbamazepine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000194	0.00391	CbGpPWpGaD
Carbamazepine—Modafinil—CYP3A4—bone cancer	0.00019	0.0542	CrCbGaD
Carbamazepine—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000187	0.00376	CbGpPWpGaD
Carbamazepine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000185	0.00372	CbGpPWpGaD
Carbamazepine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00017	0.00343	CbGpPWpGaD
Carbamazepine—Phenytoin—CYP3A4—bone cancer	0.000169	0.048	CrCbGaD
Carbamazepine—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000168	0.00338	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—JUN—bone cancer	0.000167	0.00336	CbGpPWpGaD
Carbamazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000166	0.00335	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000166	0.00335	CbGpPWpGaD
Carbamazepine—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000164	0.00331	CbGpPWpGaD
Carbamazepine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000158	0.00318	CbGpPWpGaD
Carbamazepine—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000145	0.00292	CbGpPWpGaD
Carbamazepine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000144	0.0029	CbGpPWpGaD
Carbamazepine—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000143	0.00288	CbGpPWpGaD
Carbamazepine—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000142	0.00287	CbGpPWpGaD
Carbamazepine—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000141	0.00285	CbGpPWpGaD
Carbamazepine—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000141	0.00285	CbGpPWpGaD
Carbamazepine—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000138	0.00278	CbGpPWpGaD
Carbamazepine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000136	0.00274	CbGpPWpGaD
Carbamazepine—Pollakiuria—Doxorubicin—bone cancer	0.000136	0.00115	CcSEcCtD
Carbamazepine—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000135	0.00272	CbGpPWpGaD
Carbamazepine—Haematuria—Epirubicin—bone cancer	0.000135	0.00114	CcSEcCtD
Carbamazepine—Pharyngitis—Methotrexate—bone cancer	0.000135	0.00114	CcSEcCtD
Carbamazepine—Trimipramine—CYP3A4—bone cancer	0.000135	0.0383	CrCbGaD
Carbamazepine—Urinary tract disorder—Methotrexate—bone cancer	0.000134	0.00113	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000134	0.00113	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Epirubicin—bone cancer	0.000134	0.00113	CcSEcCtD
Carbamazepine—Weight increased—Doxorubicin—bone cancer	0.000134	0.00113	CcSEcCtD
Carbamazepine—Urethral disorder—Methotrexate—bone cancer	0.000133	0.00113	CcSEcCtD
Carbamazepine—Sinusitis—Epirubicin—bone cancer	0.000133	0.00112	CcSEcCtD
Carbamazepine—Hyperglycaemia—Doxorubicin—bone cancer	0.000132	0.00112	CcSEcCtD
Carbamazepine—Agranulocytosis—Epirubicin—bone cancer	0.000132	0.00112	CcSEcCtD
Carbamazepine—Pneumonia—Doxorubicin—bone cancer	0.000132	0.00111	CcSEcCtD
Carbamazepine—SCN9A—L1CAM interactions—EGFR—bone cancer	0.000132	0.00265	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—EGFR—bone cancer	0.000131	0.00264	CbGpPWpGaD
Carbamazepine—Infestation NOS—Doxorubicin—bone cancer	0.000131	0.00111	CcSEcCtD
Carbamazepine—Drowsiness—Doxorubicin—bone cancer	0.000131	0.00111	CcSEcCtD
Carbamazepine—Infestation—Doxorubicin—bone cancer	0.000131	0.00111	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00013	0.0011	CcSEcCtD
Carbamazepine—Hypersensitivity—Cisplatin—bone cancer	0.000129	0.0011	CcSEcCtD
Carbamazepine—Bradycardia—Epirubicin—bone cancer	0.000129	0.00109	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—bone cancer	0.000129	0.00109	CcSEcCtD
Carbamazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000129	0.00259	CbGpPWpGaD
Carbamazepine—Erythema multiforme—Methotrexate—bone cancer	0.000128	0.00109	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000128	0.00109	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—bone cancer	0.000128	0.00108	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—bone cancer	0.000128	0.00108	CcSEcCtD
Carbamazepine—Rhinitis—Epirubicin—bone cancer	0.000127	0.00108	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—bone cancer	0.000127	0.00108	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—bone cancer	0.000127	0.00108	CcSEcCtD
Carbamazepine—Hepatitis—Epirubicin—bone cancer	0.000127	0.00108	CcSEcCtD
Carbamazepine—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000127	0.00256	CbGpPWpGaD
Carbamazepine—Eye disorder—Methotrexate—bone cancer	0.000127	0.00107	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—bone cancer	0.000127	0.00107	CcSEcCtD
Carbamazepine—Asthenia—Cisplatin—bone cancer	0.000126	0.00107	CcSEcCtD
Carbamazepine—Pharyngitis—Epirubicin—bone cancer	0.000126	0.00107	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—bone cancer	0.000126	0.00107	CcSEcCtD
Carbamazepine—Urinary tract disorder—Epirubicin—bone cancer	0.000125	0.00106	CcSEcCtD
Carbamazepine—Oedema peripheral—Epirubicin—bone cancer	0.000125	0.00106	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—bone cancer	0.000125	0.00106	CcSEcCtD
Carbamazepine—Connective tissue disorder—Epirubicin—bone cancer	0.000125	0.00106	CcSEcCtD
Carbamazepine—Urethral disorder—Epirubicin—bone cancer	0.000124	0.00105	CcSEcCtD
Carbamazepine—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000124	0.0025	CbGpPWpGaD
Carbamazepine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000124	0.0025	CbGpPWpGaD
Carbamazepine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000124	0.00105	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—bone cancer	0.000123	0.00104	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—bone cancer	0.000123	0.00104	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—bone cancer	0.000123	0.00104	CcSEcCtD
Carbamazepine—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000122	0.00246	CbGpPWpGaD
Carbamazepine—Mediastinal disorder—Methotrexate—bone cancer	0.000122	0.00104	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—bone cancer	0.000122	0.00103	CcSEcCtD
Carbamazepine—Chills—Methotrexate—bone cancer	0.000122	0.00103	CcSEcCtD
Carbamazepine—SCN4A—L1CAM interactions—EGFR—bone cancer	0.000121	0.00244	CbGpPWpGaD
Carbamazepine—Diarrhoea—Cisplatin—bone cancer	0.00012	0.00102	CcSEcCtD
Carbamazepine—Erythema multiforme—Epirubicin—bone cancer	0.00012	0.00102	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—bone cancer	0.00012	0.00102	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—bone cancer	0.00012	0.00101	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—bone cancer	0.000119	0.00101	CcSEcCtD
Carbamazepine—Eye disorder—Epirubicin—bone cancer	0.000119	0.001	CcSEcCtD
Carbamazepine—Tinnitus—Epirubicin—bone cancer	0.000118	0.001	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—bone cancer	0.000118	0.001	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—bone cancer	0.000118	0.001	CcSEcCtD
Carbamazepine—Flushing—Epirubicin—bone cancer	0.000118	0.000998	CcSEcCtD
Carbamazepine—Cardiac disorder—Epirubicin—bone cancer	0.000118	0.000998	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—bone cancer	0.000118	0.000998	CcSEcCtD
Carbamazepine—Desipramine—CYP3A4—bone cancer	0.000118	0.0335	CrCbGaD
Carbamazepine—Hepatitis—Doxorubicin—bone cancer	0.000118	0.000995	CcSEcCtD
Carbamazepine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000117	0.00236	CbGpPWpGaD
Carbamazepine—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000117	0.00235	CbGpPWpGaD
Carbamazepine—Pharyngitis—Doxorubicin—bone cancer	0.000117	0.000988	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—bone cancer	0.000116	0.000983	CcSEcCtD
Carbamazepine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000116	0.00233	CbGpPWpGaD
Carbamazepine—Oedema peripheral—Doxorubicin—bone cancer	0.000116	0.00098	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—bone cancer	0.000116	0.00098	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—bone cancer	0.000115	0.000978	CcSEcCtD
Carbamazepine—Angiopathy—Epirubicin—bone cancer	0.000115	0.000976	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—bone cancer	0.000115	0.000975	CcSEcCtD
Carbamazepine—Immune system disorder—Epirubicin—bone cancer	0.000115	0.000971	CcSEcCtD
Carbamazepine—Mediastinal disorder—Epirubicin—bone cancer	0.000114	0.000969	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—bone cancer	0.000114	0.000968	CcSEcCtD
Carbamazepine—Promazine—CYP3A4—bone cancer	0.000114	0.0325	CrCbGaD
Carbamazepine—Chills—Epirubicin—bone cancer	0.000114	0.000965	CcSEcCtD
Carbamazepine—Arrhythmia—Epirubicin—bone cancer	0.000113	0.000961	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—GRM4—bone cancer	0.000112	0.00227	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—RGS1—bone cancer	0.000112	0.00227	CbGpPWpGaD
Carbamazepine—Alopecia—Epirubicin—bone cancer	0.000112	0.00095	CcSEcCtD
Carbamazepine—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000112	0.00226	CbGpPWpGaD
Carbamazepine—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000112	0.00226	CbGpPWpGaD
Carbamazepine—Vomiting—Cisplatin—bone cancer	0.000112	0.000946	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—bone cancer	0.000111	0.000943	CcSEcCtD
Carbamazepine—Mental disorder—Epirubicin—bone cancer	0.000111	0.000942	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—bone cancer	0.000111	0.000941	CcSEcCtD
Carbamazepine—Rash—Cisplatin—bone cancer	0.000111	0.000938	CcSEcCtD
Carbamazepine—Dermatitis—Cisplatin—bone cancer	0.000111	0.000937	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—bone cancer	0.000111	0.000936	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—bone cancer	0.000111	0.000936	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—bone cancer	0.00011	0.00093	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—bone cancer	0.00011	0.000928	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—bone cancer	0.000109	0.000925	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—bone cancer	0.000109	0.000923	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—bone cancer	0.000109	0.000923	CcSEcCtD
Carbamazepine—Tension—Epirubicin—bone cancer	0.000108	0.000919	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—bone cancer	0.000108	0.000917	CcSEcCtD
Carbamazepine—Nervousness—Epirubicin—bone cancer	0.000107	0.000909	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—bone cancer	0.000107	0.000906	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—bone cancer	0.000107	0.000903	CcSEcCtD
Carbamazepine—Muscle spasms—Epirubicin—bone cancer	0.000106	0.0009	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—bone cancer	0.000106	0.000899	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—bone cancer	0.000106	0.000899	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—bone cancer	0.000106	0.000897	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—bone cancer	0.000106	0.000895	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—bone cancer	0.000105	0.000893	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—bone cancer	0.000105	0.000889	CcSEcCtD
Carbamazepine—Nausea—Cisplatin—bone cancer	0.000104	0.000884	CcSEcCtD
Carbamazepine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000104	0.0021	CbGpPWpGaD
Carbamazepine—Vision blurred—Epirubicin—bone cancer	0.000104	0.000882	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—bone cancer	0.000104	0.000879	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—bone cancer	0.000103	0.000872	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—bone cancer	0.000102	0.000867	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—bone cancer	0.000102	0.000866	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—bone cancer	0.000102	0.000866	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—bone cancer	0.000102	0.000865	CcSEcCtD
Carbamazepine—Agitation—Epirubicin—bone cancer	0.000102	0.00086	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—bone cancer	0.000101	0.000852	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—bone cancer	0.000101	0.000852	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—bone cancer	0.000101	0.000852	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—bone cancer	0.0001	0.00085	CcSEcCtD
Carbamazepine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.0001	0.00202	CbGpPWpGaD
Carbamazepine—Dysgeusia—Doxorubicin—bone cancer	0.0001	0.000848	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	9.99e-05	0.000846	CcSEcCtD
Carbamazepine—Imipramine—CYP3A4—bone cancer	9.98e-05	0.0284	CrCbGaD
Carbamazepine—Nervousness—Doxorubicin—bone cancer	9.93e-05	0.000841	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—bone cancer	9.93e-05	0.000841	CcSEcCtD
Carbamazepine—CYP3A7—Biological oxidations—CYP3A4—bone cancer	9.91e-05	0.002	CbGpPWpGaD
Carbamazepine—Syncope—Epirubicin—bone cancer	9.91e-05	0.00084	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—bone cancer	9.9e-05	0.000838	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—bone cancer	9.89e-05	0.000838	CcSEcCtD
Carbamazepine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	9.89e-05	0.00199	CbGpPWpGaD
Carbamazepine—Muscle spasms—Doxorubicin—bone cancer	9.83e-05	0.000833	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—MET—bone cancer	9.81e-05	0.00198	CbGpPWpGaD
Carbamazepine—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	9.78e-05	0.00197	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—GRM1—bone cancer	9.75e-05	0.00196	CbGpPWpGaD
Carbamazepine—Confusional state—Methotrexate—bone cancer	9.72e-05	0.000823	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—bone cancer	9.72e-05	0.000823	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—bone cancer	9.64e-05	0.000816	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—bone cancer	9.64e-05	0.000816	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—bone cancer	9.58e-05	0.000811	CcSEcCtD
Carbamazepine—Infection—Methotrexate—bone cancer	9.58e-05	0.000811	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—bone cancer	9.54e-05	0.000808	CcSEcCtD
Carbamazepine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.51e-05	0.00192	CbGpPWpGaD
Carbamazepine—Nervous system disorder—Methotrexate—bone cancer	9.45e-05	0.000801	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—bone cancer	9.45e-05	0.000801	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—bone cancer	9.44e-05	0.000799	CcSEcCtD
Carbamazepine—Chest pain—Epirubicin—bone cancer	9.41e-05	0.000797	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—bone cancer	9.41e-05	0.000797	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—bone cancer	9.41e-05	0.000797	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—bone cancer	9.4e-05	0.000796	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—bone cancer	9.38e-05	0.000794	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—bone cancer	9.36e-05	0.000793	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	9.35e-05	0.000791	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—bone cancer	9.32e-05	0.000789	CcSEcCtD
Carbamazepine—Dry mouth—Epirubicin—bone cancer	9.2e-05	0.000779	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—bone cancer	9.19e-05	0.000778	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—bone cancer	9.19e-05	0.000778	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—bone cancer	9.17e-05	0.000777	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—bone cancer	9.16e-05	0.000775	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—bone cancer	9.1e-05	0.00077	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—bone cancer	9.02e-05	0.000764	CcSEcCtD
Carbamazepine—Anaphylactic shock—Epirubicin—bone cancer	9.02e-05	0.000764	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—MET—bone cancer	9.02e-05	0.00182	CbGpPWpGaD
Carbamazepine—Hypotension—Methotrexate—bone cancer	9.01e-05	0.000763	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—bone cancer	8.99e-05	0.000761	CcSEcCtD
Carbamazepine—Infection—Epirubicin—bone cancer	8.96e-05	0.000759	CcSEcCtD
Carbamazepine—Shock—Epirubicin—bone cancer	8.88e-05	0.000752	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—bone cancer	8.86e-05	0.00075	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—bone cancer	8.85e-05	0.000749	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—bone cancer	8.83e-05	0.000748	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—bone cancer	8.83e-05	0.000748	CcSEcCtD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.82e-05	0.00178	CbGpPWpGaD
Carbamazepine—Tachycardia—Epirubicin—bone cancer	8.81e-05	0.000746	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—bone cancer	8.78e-05	0.000744	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—bone cancer	8.76e-05	0.000742	CcSEcCtD
Carbamazepine—Hyperhidrosis—Epirubicin—bone cancer	8.72e-05	0.000739	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—bone cancer	8.72e-05	0.000738	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—bone cancer	8.71e-05	0.000737	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—bone cancer	8.71e-05	0.000737	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—bone cancer	8.71e-05	0.000737	CcSEcCtD
Carbamazepine—UGT2B7—Metabolism—NDUFA12—bone cancer	8.7e-05	0.00175	CbGpPWpGaD
Carbamazepine—Anxiety—Doxorubicin—bone cancer	8.68e-05	0.000735	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—bone cancer	8.66e-05	0.000733	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	8.65e-05	0.000732	CcSEcCtD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.62e-05	0.00174	CbGpPWpGaD
Carbamazepine—Anorexia—Epirubicin—bone cancer	8.6e-05	0.000728	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—bone cancer	8.6e-05	0.000728	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—bone cancer	8.57e-05	0.000726	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—bone cancer	8.52e-05	0.000721	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—bone cancer	8.49e-05	0.000719	CcSEcCtD
Carbamazepine—CYP3A7—Biological oxidations—GSTP1—bone cancer	8.48e-05	0.00171	CbGpPWpGaD
Carbamazepine—Hypotension—Epirubicin—bone cancer	8.43e-05	0.000714	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—bone cancer	8.42e-05	0.000713	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—bone cancer	8.38e-05	0.00071	CcSEcCtD
Carbamazepine—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	8.36e-05	0.00168	CbGpPWpGaD
Carbamazepine—Oedema—Doxorubicin—bone cancer	8.35e-05	0.000707	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—bone cancer	8.35e-05	0.000707	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—bone cancer	8.32e-05	0.000705	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—bone cancer	8.31e-05	0.000704	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—bone cancer	8.29e-05	0.000702	CcSEcCtD
Carbamazepine—Pain—Methotrexate—bone cancer	8.24e-05	0.000698	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—bone cancer	8.22e-05	0.000696	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—bone cancer	8.21e-05	0.000695	CcSEcCtD
Carbamazepine—SCN5A—L1CAM interactions—EGFR—bone cancer	8.2e-05	0.00165	CbGpPWpGaD
Carbamazepine—Nervous system disorder—Doxorubicin—bone cancer	8.19e-05	0.000693	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—MMP2—bone cancer	8.18e-05	0.00165	CbGpPWpGaD
Carbamazepine—Thrombocytopenia—Doxorubicin—bone cancer	8.17e-05	0.000692	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—bone cancer	8.16e-05	0.000691	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—bone cancer	8.15e-05	0.00069	CcSEcCtD
Carbamazepine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	8.13e-05	0.00164	CbGpPWpGaD
Carbamazepine—Skin disorder—Doxorubicin—bone cancer	8.11e-05	0.000687	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—bone cancer	8.1e-05	0.000686	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—bone cancer	8.07e-05	0.000683	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—bone cancer	8.04e-05	0.000681	CcSEcCtD
Carbamazepine—Somnolence—Epirubicin—bone cancer	8.02e-05	0.000679	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—bone cancer	7.96e-05	0.000674	CcSEcCtD
Carbamazepine—Feeling abnormal—Methotrexate—bone cancer	7.94e-05	0.000673	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—bone cancer	7.94e-05	0.000673	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—bone cancer	7.88e-05	0.000668	CcSEcCtD
Carbamazepine—Decreased appetite—Epirubicin—bone cancer	7.84e-05	0.000664	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—bone cancer	7.8e-05	0.000661	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—bone cancer	7.79e-05	0.00066	CcSEcCtD
Carbamazepine—Fatigue—Epirubicin—bone cancer	7.78e-05	0.000659	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—bone cancer	7.72e-05	0.000653	CcSEcCtD
Carbamazepine—Pain—Epirubicin—bone cancer	7.72e-05	0.000653	CcSEcCtD
Carbamazepine—Urticaria—Methotrexate—bone cancer	7.66e-05	0.000649	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—bone cancer	7.62e-05	0.000645	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—bone cancer	7.62e-05	0.000645	CcSEcCtD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.61e-05	0.00153	CbGpPWpGaD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—bone cancer	7.61e-05	0.000644	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—bone cancer	7.55e-05	0.000639	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—MMP2—bone cancer	7.52e-05	0.00152	CbGpPWpGaD
Carbamazepine—Paraesthesia—Doxorubicin—bone cancer	7.5e-05	0.000635	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—bone cancer	7.44e-05	0.00063	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—bone cancer	7.44e-05	0.00063	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—bone cancer	7.42e-05	0.000628	CcSEcCtD
Carbamazepine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	7.39e-05	0.00149	CbGpPWpGaD
Carbamazepine—Gastrointestinal pain—Epirubicin—bone cancer	7.38e-05	0.000625	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—bone cancer	7.35e-05	0.000622	CcSEcCtD
Carbamazepine—CYP2B6—Biological oxidations—CYP3A4—bone cancer	7.33e-05	0.00148	CbGpPWpGaD
Carbamazepine—Decreased appetite—Doxorubicin—bone cancer	7.26e-05	0.000615	CcSEcCtD
Carbamazepine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	7.23e-05	0.00146	CbGpPWpGaD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—bone cancer	7.21e-05	0.00061	CcSEcCtD
Carbamazepine—UGT2B7—Metabolism—NT5C3A—bone cancer	7.21e-05	0.00145	CbGpPWpGaD
Carbamazepine—Fatigue—Doxorubicin—bone cancer	7.2e-05	0.000609	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—bone cancer	7.17e-05	0.000607	CcSEcCtD
Carbamazepine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	7.17e-05	0.00144	CbGpPWpGaD
Carbamazepine—Pain—Doxorubicin—bone cancer	7.14e-05	0.000605	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—bone cancer	7.14e-05	0.000605	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—bone cancer	7.13e-05	0.000604	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—bone cancer	7.13e-05	0.000604	CcSEcCtD
Carbamazepine—Hypersensitivity—Methotrexate—bone cancer	7.1e-05	0.000601	CcSEcCtD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—JUN—bone cancer	7.07e-05	0.00142	CbGpPWpGaD
Carbamazepine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	7.07e-05	0.00142	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	7.05e-05	0.00142	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MET—bone cancer	7e-05	0.00141	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CDK4—bone cancer	7e-05	0.00141	CbGpPWpGaD
Carbamazepine—Asthenia—Methotrexate—bone cancer	6.92e-05	0.000586	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—bone cancer	6.88e-05	0.000583	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—SMO—bone cancer	6.87e-05	0.00138	CbGpPWpGaD
Carbamazepine—Gastrointestinal pain—Doxorubicin—bone cancer	6.83e-05	0.000578	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—bone cancer	6.82e-05	0.000578	CcSEcCtD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	6.68e-05	0.00135	CbGpPWpGaD
Carbamazepine—Hypersensitivity—Epirubicin—bone cancer	6.65e-05	0.000563	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—bone cancer	6.63e-05	0.000562	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—bone cancer	6.6e-05	0.000559	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—bone cancer	6.6e-05	0.000559	CcSEcCtD
Carbamazepine—Diarrhoea—Methotrexate—bone cancer	6.6e-05	0.000559	CcSEcCtD
Carbamazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	6.6e-05	0.00133	CbGpPWpGaD
Carbamazepine—Asthenia—Epirubicin—bone cancer	6.47e-05	0.000548	CcSEcCtD
Carbamazepine—SCN4A—Developmental Biology—CDK4—bone cancer	6.43e-05	0.0013	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MET—bone cancer	6.43e-05	0.0013	CbGpPWpGaD
Carbamazepine—Pruritus—Epirubicin—bone cancer	6.38e-05	0.000541	CcSEcCtD
Carbamazepine—Dizziness—Methotrexate—bone cancer	6.38e-05	0.00054	CcSEcCtD
Carbamazepine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	6.31e-05	0.00127	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—GNA11—bone cancer	6.28e-05	0.00127	CbGpPWpGaD
Carbamazepine—CYP2B6—Biological oxidations—GSTP1—bone cancer	6.27e-05	0.00126	CbGpPWpGaD
Carbamazepine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.21e-05	0.00125	CbGpPWpGaD
Carbamazepine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	6.18e-05	0.00125	CbGpPWpGaD
Carbamazepine—Diarrhoea—Epirubicin—bone cancer	6.17e-05	0.000523	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—MMP9—bone cancer	6.15e-05	0.00124	CbGpPWpGaD
Carbamazepine—Hypersensitivity—Doxorubicin—bone cancer	6.15e-05	0.000521	CcSEcCtD
Carbamazepine—Vomiting—Methotrexate—bone cancer	6.13e-05	0.000519	CcSEcCtD
Carbamazepine—CYP3A5—Biological oxidations—GSTP1—bone cancer	6.13e-05	0.00123	CbGpPWpGaD
Carbamazepine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.12e-05	0.00123	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MET—bone cancer	6.11e-05	0.00123	CbGpPWpGaD
Carbamazepine—Rash—Methotrexate—bone cancer	6.08e-05	0.000515	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—bone cancer	6.07e-05	0.000514	CcSEcCtD
Carbamazepine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	6.05e-05	0.00122	CbGpPWpGaD
Carbamazepine—Headache—Methotrexate—bone cancer	6.04e-05	0.000511	CcSEcCtD
Carbamazepine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	6.01e-05	0.00121	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	6e-05	0.00121	CbGpPWpGaD
Carbamazepine—Asthenia—Doxorubicin—bone cancer	5.99e-05	0.000507	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—bone cancer	5.97e-05	0.000505	CcSEcCtD
Carbamazepine—CYP3A7—Metabolism—NDUFA12—bone cancer	5.94e-05	0.0012	CbGpPWpGaD
Carbamazepine—Pruritus—Doxorubicin—bone cancer	5.91e-05	0.0005	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—ATF1—bone cancer	5.84e-05	0.00118	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MMP2—bone cancer	5.84e-05	0.00118	CbGpPWpGaD
Carbamazepine—Vomiting—Epirubicin—bone cancer	5.74e-05	0.000486	CcSEcCtD
Carbamazepine—Nausea—Methotrexate—bone cancer	5.73e-05	0.000485	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—bone cancer	5.71e-05	0.000484	CcSEcCtD
Carbamazepine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	5.7e-05	0.00115	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL3—bone cancer	5.7e-05	0.00115	CbGpPWpGaD
Carbamazepine—Rash—Epirubicin—bone cancer	5.69e-05	0.000482	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—bone cancer	5.68e-05	0.000481	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—MMP9—bone cancer	5.65e-05	0.00114	CbGpPWpGaD
Carbamazepine—Headache—Epirubicin—bone cancer	5.65e-05	0.000479	CcSEcCtD
Carbamazepine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	5.54e-05	0.00112	CbGpPWpGaD
Carbamazepine—Dizziness—Doxorubicin—bone cancer	5.52e-05	0.000467	CcSEcCtD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	5.49e-05	0.00111	CbGpPWpGaD
Carbamazepine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	5.46e-05	0.0011	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.46e-05	0.0011	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MMP2—bone cancer	5.37e-05	0.00108	CbGpPWpGaD
Carbamazepine—Nausea—Epirubicin—bone cancer	5.36e-05	0.000454	CcSEcCtD
Carbamazepine—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.31e-05	0.00107	CbGpPWpGaD
Carbamazepine—Vomiting—Doxorubicin—bone cancer	5.31e-05	0.000449	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—bone cancer	5.26e-05	0.000446	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—bone cancer	5.26e-05	0.000445	CcSEcCtD
Carbamazepine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.24e-05	0.00105	CbGpPWpGaD
Carbamazepine—Headache—Doxorubicin—bone cancer	5.23e-05	0.000443	CcSEcCtD
Carbamazepine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	5.14e-05	0.00104	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MMP2—bone cancer	5.1e-05	0.00103	CbGpPWpGaD
Carbamazepine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	5.05e-05	0.00102	CbGpPWpGaD
Carbamazepine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	4.98e-05	0.001	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.97e-05	0.001	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—EGFR—bone cancer	4.97e-05	0.001	CbGpPWpGaD
Carbamazepine—Nausea—Doxorubicin—bone cancer	4.96e-05	0.00042	CcSEcCtD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	4.95e-05	0.000998	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NT5C3A—bone cancer	4.92e-05	0.000992	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.91e-05	0.000988	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TGFBR2—bone cancer	4.87e-05	0.000982	CbGpPWpGaD
Carbamazepine—CYP2C19—Biological oxidations—GSTP1—bone cancer	4.74e-05	0.000955	CbGpPWpGaD
Carbamazepine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	4.67e-05	0.000941	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.65e-05	0.000936	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IGF1R—bone cancer	4.58e-05	0.000923	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—EGFR—bone cancer	4.57e-05	0.00092	CbGpPWpGaD
Carbamazepine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.4e-05	0.000886	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NDUFA12—bone cancer	4.39e-05	0.000885	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MMP9—bone cancer	4.39e-05	0.000884	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MET—bone cancer	4.36e-05	0.000879	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CDK4—bone cancer	4.36e-05	0.000879	CbGpPWpGaD
Carbamazepine—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.32e-05	0.00087	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	4.32e-05	0.00087	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NDUFA12—bone cancer	4.3e-05	0.000865	CbGpPWpGaD
Carbamazepine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.26e-05	0.000858	CbGpPWpGaD
Carbamazepine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	4.26e-05	0.000858	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.16e-05	0.000837	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.15e-05	0.000835	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MMP9—bone cancer	4.03e-05	0.000813	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.89e-05	0.000785	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	3.89e-05	0.000785	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MMP9—bone cancer	3.83e-05	0.000772	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NDUFA12—bone cancer	3.72e-05	0.000749	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—GSTP1—bone cancer	3.69e-05	0.000744	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NT5C3A—bone cancer	3.64e-05	0.000734	CbGpPWpGaD
Carbamazepine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	3.64e-05	0.000734	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MMP2—bone cancer	3.64e-05	0.000733	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.58e-05	0.000721	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NT5C3A—bone cancer	3.56e-05	0.000717	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EGFR—bone cancer	3.55e-05	0.000715	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KIT—bone cancer	3.32e-05	0.00067	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NDUFA12—bone cancer	3.32e-05	0.000669	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EGFR—bone cancer	3.26e-05	0.000657	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NDUFA12—bone cancer	3.24e-05	0.000653	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ENO2—bone cancer	3.16e-05	0.000636	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—BRAF—bone cancer	3.13e-05	0.00063	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—EGFR—bone cancer	3.1e-05	0.000624	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.08e-05	0.000621	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NT5C3A—bone cancer	3.08e-05	0.000621	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NDUFA12—bone cancer	3.03e-05	0.00061	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—DHFR—bone cancer	2.93e-05	0.00059	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.85e-05	0.000574	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.81e-05	0.000566	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NT5C3A—bone cancer	2.75e-05	0.000554	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GNA11—bone cancer	2.74e-05	0.000551	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MMP9—bone cancer	2.73e-05	0.000551	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NT5C3A—bone cancer	2.69e-05	0.000541	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MDM2—bone cancer	2.62e-05	0.000527	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NDUFA12—bone cancer	2.59e-05	0.000521	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NT5C3A—bone cancer	2.51e-05	0.000505	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CYP3A4—bone cancer	2.48e-05	0.0005	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.29e-05	0.00046	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—JUN—bone cancer	2.28e-05	0.000458	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MMP9—bone cancer	2.21e-05	0.000446	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EGFR—bone cancer	2.21e-05	0.000445	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.2e-05	0.000444	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ENO2—bone cancer	2.16e-05	0.000434	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NT5C3A—bone cancer	2.14e-05	0.000432	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GSTP1—bone cancer	2.12e-05	0.000427	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—DHFR—bone cancer	2e-05	0.000403	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NDUFA12—bone cancer	2e-05	0.000402	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.99e-05	0.0004	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GNA11—bone cancer	1.87e-05	0.000377	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—bone cancer	1.79e-05	0.00036	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP3A4—bone cancer	1.7e-05	0.000342	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.65e-05	0.000333	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ENO2—bone cancer	1.6e-05	0.000321	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.56e-05	0.000315	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ENO2—bone cancer	1.56e-05	0.000314	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—bone cancer	1.5e-05	0.000303	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—DHFR—bone cancer	1.48e-05	0.000298	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GSTP1—bone cancer	1.45e-05	0.000292	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—DHFR—bone cancer	1.45e-05	0.000291	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNA11—bone cancer	1.38e-05	0.000279	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNA11—bone cancer	1.35e-05	0.000272	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ENO2—bone cancer	1.35e-05	0.000272	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.31e-05	0.000264	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP3A4—bone cancer	1.25e-05	0.000253	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—DHFR—bone cancer	1.25e-05	0.000252	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP3A4—bone cancer	1.23e-05	0.000247	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ENO2—bone cancer	1.21e-05	0.000243	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO2—bone cancer	1.18e-05	0.000237	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNA11—bone cancer	1.17e-05	0.000236	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—DHFR—bone cancer	1.12e-05	0.000225	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—bone cancer	1.1e-05	0.000221	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO2—bone cancer	1.1e-05	0.000221	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—DHFR—bone cancer	1.09e-05	0.00022	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTP1—bone cancer	1.07e-05	0.000216	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.06e-05	0.000214	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.06e-05	0.000213	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTP1—bone cancer	1.05e-05	0.000211	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNA11—bone cancer	1.05e-05	0.000211	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNA11—bone cancer	1.02e-05	0.000205	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—DHFR—bone cancer	1.02e-05	0.000205	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNA11—bone cancer	9.53e-06	0.000192	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP3A4—bone cancer	9.48e-06	0.000191	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.43e-06	0.00019	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—bone cancer	9.39e-06	0.000189	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP3A4—bone cancer	9.25e-06	0.000186	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTP1—bone cancer	9.08e-06	0.000183	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—DHFR—bone cancer	8.71e-06	0.000176	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP3A4—bone cancer	8.64e-06	0.000174	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.6e-06	0.000173	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNA11—bone cancer	8.14e-06	0.000164	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTP1—bone cancer	8.1e-06	0.000163	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTP1—bone cancer	7.91e-06	0.000159	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—bone cancer	7.51e-06	0.000151	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTP1—bone cancer	7.39e-06	0.000149	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP3A4—bone cancer	7.38e-06	0.000149	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.35e-06	0.000148	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—bone cancer	7.25e-06	0.000146	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—DHFR—bone cancer	6.72e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTP1—bone cancer	6.31e-06	0.000127	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNA11—bone cancer	6.28e-06	0.000127	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—bone cancer	5.56e-06	0.000112	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—bone cancer	5.43e-06	0.000109	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTP1—bone cancer	4.87e-06	9.82e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—bone cancer	4.7e-06	9.47e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—bone cancer	4.2e-06	8.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—bone cancer	4.1e-06	8.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—bone cancer	3.83e-06	7.71e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—bone cancer	3.27e-06	6.59e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—bone cancer	2.52e-06	5.09e-05	CbGpPWpGaD
